Canget BioTekpharma, LLC (Canget) is a biotech and biopharma company, and was spun off in 2012 from Roswell Park Cancer Institute (RPCI, Buffalo, New York). Canget focuses on the development of novel, cancer-targeting anticancer agents that exhibit low toxicity to normal tissue and high efficacy to cancer.

Biotechnology

Canget BioTekpharma

Canget BioTekpharma's headquarters in Buffalo, NY, United States

John J. Seman

Alex A. Adjei

Fengzhi Li

Scott Friedman

Youcef M. Rustum

Martin K. Casstevens

Carl Porter

Ravindra K Pandey

Nathan R. Wall

Lili Tian

Brian R. Pettit

Gerald Fetterly, Jr.

Description

People

Jobs